sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Europe Virus-like Particles Market...

2028년까지 유럽 바이러스 유사 입자 시장 예측 - 제품 유형(간염, 암/HPV 및 고셔병), 출처(효모, 곤충 세포, 식물 및 기타) 및 응용 분야(백신 및 치료학)

TIPRE00026818 | Pages: 122 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

시장 소개

유럽은 독일, 프랑스, 영국, 이탈리아 등 5개의 주요 국가로 구성됩니다. , 그리고 스페인. 시장은 유럽의 나머지 국가로도 구성됩니다. 유럽의 바이러스 유사 입자 시장은 당국의 신제품 승인으로 인해 더욱 강력한 성장을 보이고 있습니다. 예를 들어, 최초의 허가된 말라리아 VLP 기반 백신인 \"Mosquirix\"는 유럽 규제 당국의 승인을 받았습니다. 또한 영국, 독일, 프랑스, 이탈리아, 스페인과 같은 국가는 유럽에서 바이러스 유사 입자 제품에 대한 수요를 주도하는 주요 기여 국가입니다.

세계보건기구(WHO) 보고서에 따르면 현재 유럽의 모든 국가는 코로나19로 인한 실질적인 위협에 직면해 있습니다. WHO 유럽 지역 53개국에서의 바이러스 전파 속도는 우려할 만한 문제입니다. 전파를 통제하기 위해 유럽 국가들은 다양한 단계에서 백신 접종을 실시하고 있습니다. 유럽에서는 현재 영국, 독일, 러시아 등에서 다양한 코로나19 백신이 개발돼 임상시험 중이다. 그 중 영국에는 3개, 독일에는 3개, 러시아에는 2개의 백신이 있습니다. 이들 백신 중에는 불활성화 백신 1종, 단백질 아단위 2종, 바이러스 벡터 백신 3종, 핵산 백신 2종이 있다. 유럽 지역의 코로나바이러스에 맞서기 위해 유럽 전체는 백신 개발을 추진하기 위해 일관된 노력을 기울여 왔습니다. Bruegel 보고서에 따르면 EU는 코로나19 팬데믹 이전에 2014~2020년 동안 Horizon 2020 연구 프로그램을 통해 백신 및 예방접종 연구에 약 5억 달러의 자금을 지원한다고 발표했습니다. 또한, 코로나19에 대처하기 위해 EU는 진단, 치료제, 백신에 대한 연구 개발을 지원하기 위한 긴급 자금을 제공했습니다. 당초 1,000만 달러는 이후 4,750만 달러로 늘어나 코로나19 팬데믹 대응을 위한 연구 프로젝트에 배정됐다. 또한, 2020년 4월에 개교한 유럽 기술 보건 연구소(European Institute of Technology Health)는 EIT 파트너에게 각 프로젝트의 자금 지원을 통해 강력한 구현을 통해 코로나19 프로젝트에 대한 제안서를 보내도록 요청했습니다.

< Strong>시장 개요 및 역학

유럽의 바이러스 유사 입자 시장은 2021년 13억 203만 달러에서 성장할 것으로 예상됩니다. 2028년까지 미화 22억 361만 달러; 2021년부터 2028년까지 CAGR 7.8%로 성장할 것으로 예상됩니다. 백신은 제약 산업의 중요한 부문 중 하나를 형성합니다. 이는 일반적인 감염에 대한 인간과 동물의 면역화에 광범위하게 적용됩니다. 제약 및 바이오의약품 시장에서 활동하는 회사들은 시장에서 경쟁을 유지하기 위해 지속적으로 제품 혁신과 개발에 중점을 두고 있습니다. 예를 들어, 시장 참여자들은 코로나19 백신 개발과 VLP 관련 연구에 상당한 투자를 해왔습니다. 생명과학 기업의 적극적인 개발과 이에 대한 정부 지원이 VLP 시장 성장에 기여하고 있습니다.

주요 시장 부문

제품 유형 측면에서 간염 부문은 2021년 유럽 바이러스 유사 입자 시장에서 가장 큰 점유율을 차지했습니다. 출처 측면에서, 효모 부문은 2021년 유럽 바이러스 유사 입자 시장에서 가장 큰 점유율을 차지했습니다. 적용 측면에서 백신 부문은 2021년 바이러스 유사 입자 시장에서 더 큰 시장 점유율을 차지했습니다.

나열된 주요 출처 및 회사

이 보고서를 준비하는 데 참고된 몇 가지 주요 1차 및 2차 출처 유럽의 바이러스 유사 입자 시장에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Merck & 주식회사; GlaxoSmithKline plc.; 화이자 주식회사; 사노피; 인도 혈청 연구소 Pvt. 주식회사; 바라트 생명공학; LG화학; 및 Dynavax Technologies.

구매 이유 보고서

  • 유럽의 바이러스 유사 입자 시장 환경을 이해하고 강력한 수익을 보장할 가능성이 가장 높은 시장 부문을 식별합니다.
  • 유럽 바이러스 유사 입자 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가세요
  • 효율적인 M& 계획 ;가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 유럽 바이러스 유사 입자 시장에서 A와 파트너십 거래
  • 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다. 유럽 바이러스 유사 입자 시장 형태의 다양한 세그먼트
  • 2021~2028년 유럽 지역의 다양한 세그먼트별 시장 수익 예측을 얻으세요.

유럽 바이러스 유사 입자 시장 세분화

 

유럽 바이러스 유사 입자 시장 - 제품 유형별

  • 간염
  • 암/HPV
  • 고셔병

유럽 바이러스 유사 입자 시장 - 출처별

  • 효모
  • 곤충 세포
  • 식물
  • 기타

유럽 바이러스 유사 입자 시장 - 기준 애플리케이션

  • 백신
  • 치료학

유럽 바이러스 유사 입자 시장 - 국가

  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 유럽 나머지 지역    

유럽 바이러스 유사 입자 시장 - 언급된 회사

  • Merck & 주식회사                        ;                        &n bsp ;       
  • GlaxoSmithKline plc.
  • 화이자 주식회사  ;                        &n bsp ;                        &n bsp ;                 
  • 사노피  ;                        &n bsp ;                        &n bsp ;                        
  • Serum Institute of India Pvt. Ltd.                             
  • BHARAT 생명공학                ;                        &n bsp ;               
  • LG화학                             ;                           ;                 
  • Dynavax Technologies          
1.            Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Virus-like Particles Market – By Product Type

1.3.2        Europe Virus-like Particles Market – By Source

1.3.3        Europe Virus-like Particles Market – By Application

1.3.4        Europe Virus-like Particles Market – By Country

2.           Europe Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Europe Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Raising Prevalence of Infectious Viral Diseases

5.1.2        The Growing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Access of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Boosting Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Ongoing Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Europe Virus-like Particles Market Analysis

6.1         Europe Virus-like Particles Market Revenue Forecast and Analysis

7.           Europe Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Europe Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Europe Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)

10.1.1.1       Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.5       Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.5       France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4       Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Europe: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4       Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Europe Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Europe Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Dynavax Technologies

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Serum Institute of India Pvt. Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BHARAT BIOTECH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      LG Chem

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Europe Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 7.             France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 16.          Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20.          Organic Developments Done by Companies

Table 21.          Inorganic Developments Done by Companies

Table 22.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           Europe Virus-like particles Market Segmentation

Figure 2.           Europe Virus-like particles Market Segmentation, By Country

Figure 3.           Europe Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Europe Virus-like particles Market

Figure 5.           The UK to Show Significant Growth during Forecast Period

Figure 6.           Europe Virus-like Particles Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Europe Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Europe Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Europe Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Europe: Virus-like Particles Market, by Key Country – Revenue (2021) (USD Million)

Figure 23.        Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)

Figure 24.        Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in European Country Markets

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  8. Dynavax Technologies                                             
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription